BIS Research Study Highlights the Global CRISPR Gene Editing Market to Reach $18.85 Billion by 2031 – PRNewswire

FREMONT, Calif., Dec. 9, 2021 /PRNewswire/ -- The global CRISPR gene editing marketis projected to reach $18.85 billion by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 29.60% during the forecast period 2021-2031.

The development of genome engineering with potential applications proved to reflect a remarkable impact on the future of the healthcare and life science industry. The high efficiency of the CRISPR-Cas9 system has been demonstrated in various studies for genome editing, which resulted in significant investments within the field of genome engineering. However, with so many advantages, limitations also exist, which need consideration before clinical applications.

The detailed study is a compilation of 09 Market Data Tables and 238 Figures spread through 296 Pages and in-depth TOC on "Global CRISPR Gene Editing Market Analysis and Forecast, 2021-2031"

USP of the report

Analyst's Take on the Market:

To emphasize the dominance of the kits and enzymes segment of CRISPR products market segment over other segments under the product category of CRISPR gene editing market in 2021 and 2031, Nitish Kumar, Lead Analyst BIS Research, states, "The reason for market growth and the dominance of CRISPR products market segment can be attributed to increasing global geriatric population, prevalence of genetic disorders, chronic conditions, rising focus on research and development (R&D) of novel gene therapies, increased government and private funding for improved safety and outcomes provided by the CRISPR gene editing products."

View the Reportfrom BIS Research at Global CRISPR Gene Editing Market

Key Companies Operating in the Market and Competition Landscape

Key insights are drawn from in-depth interviews with the key opinion leaders of more than 20 leading companies, market participants, and vendors. The key players profiled in the report include Abcam plc., Agilent Technologies, Inc., Applied StemCell, Inc., Cellecta, Inc., CRISPR Therapeutics, OriGene Technologies, Inc., GeneCopoeia, Inc., Genscript Biotech Corporation, Horizon Discovery Group Plc, Integrated DNA Technologies (IDT), Inc., Merck KGaA, New England Biolabs, Inc., Rockland Immunochemicals, Inc., Synthego Corporation, System Biosciences, LLC, Thermo Fisher Scientific Inc., ToolGen, Inc., Intellia Therapeutics, Inc., Editas Medicine, Takara Bio, Inc., and Caribou Biosciences, Inc.

The study also offers strategic recommendations that can help organizations track various products, trends, and technologies that are changing the market dynamics. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.

Who should buy this report?

Request for a Sample: https://bisresearch.com/requestsample?id=1210&type=download

Key Questions Answered in the Report:

BIS Research Related Market Studies:

Global Cell and Gene Therapy Market - Analysis and Forecast, 2019-2025

About BIS Research:

BIS Researchis a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.

Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape.

BIS Healthcare vertical offers intelligence in the healthcare technology market for Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, Precision Medicine, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 5 years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform for the past two years successfully.

Contact:Bhavya BangaEmail: [emailprotected] BIS Research Inc.39111 PASEO PADRE PKWY STE 313,FREMONT CA 94538-1686Visit our Blog @ https://blog.bisresearch.com/ Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-researchConnect with us on [emailprotected] https://twitter.com/BISResearch

SOURCE BIS Research

Read more from the original source:
BIS Research Study Highlights the Global CRISPR Gene Editing Market to Reach $18.85 Billion by 2031 - PRNewswire